Treating Adenovirus Infection in Transplant Populations: Therapeutic Options Beyond Cidofovir?
Adenovirus (AdV) infections can lead to significant morbidity and increased mortality in immunocompromised populations such as hematopoietic stem cell and solid organ transplant recipients. This review evaluates currently available and emerging therapies for AdV infections. Cidofovir, while most com...
Saved in:
| Main Authors: | Niyati Narsana, David Ha, Dora Y. Ho |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/17/5/599 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Resolution of painful trichodysplasia spinulosa with topical cidofovir: case report
by: Kevin M. Burningham, et al.
Published: (2024-12-01) -
Disseminated Mpox infection, a rare case of an immunocompromised patient treated with tecovirimat and brincidofovir
by: Paytra A. Klein, MBA, et al.
Published: (2025-05-01) -
Adenovirüs ve Rotavirüs Gastroenterit Sıklığının Araştırılması
by: Salih Maçin, et al.
Published: (2021-04-01) -
Decorin-armed oncolytic adenovirus promotes natural killers (NKs) activation and infiltration to enhance NK therapy in CRC model
by: Xue Li, et al.
Published: (2024-11-01) -
Dual Resistance to Maribavir and Ganciclovir in Transplant Recipients
by: Steven B. Kleiboeker
Published: (2025-03-01)